SBC Medical Group Holdings Incorporated (SBC) Stock Forecast & Price Target

SBC Medical Group Holdings Incorporated (SBC) has an ST Score of 66.5 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate SBC a Buy, with a price target of $12.00 (+119.8% vs the current price). Our ST Score grades it B (66.5/100). The ST Score is a data-driven signal, not a recommendation.

Valuation C, Profitability A-, Financial Strength A, Momentum A, Growth D, Forecast A.

SBC Medical Group Holdings Incorporated (SBC) earns a valuation grade of C, measured against Consulting Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

SBC Medical Group Holdings Incorporated (SBC) earns a growth grade of D, measured against Consulting Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

SBC Medical Group Holdings Incorporated (SBC) earns a profitability grade of A-, measured against Consulting Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

SBC Medical Group Holdings Incorporated (SBC) earns a financial strength grade of A, measured against Consulting Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for SBC Medical Group Holdings Incorporated (SBC) is $12.00 from 1 analysts, which is +119.8% versus the recent price of $5.46.

SBC Medical Group Holdings Incorporated (SBC) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.